Daniel Cox is a Cardiology physician affiliated with Intermountain Healthcare. OpenAlex indexes 18 publications with 285 citations (h-index 8); ClinicalTrials.gov lists 11 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
100 N Mario Capecchi Dr
Salt Lake City, UT 841131103
Telephone
801-662-5400Provider last certified this registry record 12 Nov 2021.
Clinical trials
- The Use of Libre to Improve Metabolic Control and Reduce Reliance on Medication
Sponsor: University of Virginia
- Benefits of Continuous Glucose Monitoring With GEM Lifestyle Modification for Adults With Type 2 Diabetes
Sponsor: University of Virginia
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20252 payments
- Medtronic, Inc.Program year20241 payment
- Bayer Healthcare Pharmaceuticals Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
76.4%Beta blocker25.5%Sotalol37%Metoprolol Succinate37%Carvedilol27%Part D<11 patientsCardiac glycoside19.3%Digoxin100%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
9.3%Potassium supplement9.3%Potassium Chloride100%Part D<11 patientsGenitourinary & hormones
7.5%Phosphodiesterase 5 Inhibitor7.5%Sildenafil Citrate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- UNPLANNED INTERVENTIONS DURING ROUTINE SURVEILLANCE CATHETERIZATION IN PATIENTS WITH FONTAN CIRCULATION
Journal of the American College of Cardiology
2023 - MULTIDISCIPLINARY APPROACH TO AN INFREQUENT PROBLEM: RUPTURED SINUS OF VALSALVA ANEURYSM
Journal of the American College of Cardiology
2023 - Association between pregnancy and long-term cardiac outcomes in individuals with congenital heart disease
American Journal of Obstetrics and Gynecology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Brian Whisenant, MD
Intermountain Healthcare
William Sause, MD
Intermountain Healthcare
Nick Mamalis, MD
Intermountain Healthcare
Peggy Norton, MD
Intermountain Healthcare
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”